Impairments in attenfion and working memory are core disturbances in schizophrenia. The Central Hypothesis posits that these arise due to molecular (Project 1) and morphological (Project 2) abnormalifies in the layer 3 pyramidal cells that that interconnect the dorsolateral prefrontal cortex (DLPFC) and posterior parietal cortex (PPC). The goal of Project 5 is use information from the normal properties of PPC-DLPFC circuitry in monkeys (Projects 3 and 4) to determine how these cellular abnormalifies give rise to cortical network and cognitive disturbances in medication naive, first-episode psychosis. We will use tasks that rely to different degrees on 'bottom-up'or 'top-down'processing to determine how activity within and communicafion between DLPFC and PPC are impaired, whether such disturbances are reflected equally or differentially in 'bottom-up'and 'top-down'processing, and if cortical oscillations provide signatures for such local and distributed circuit disturbances. We will employ a mulfimodal imaging approach taking advantage of the high temporal resolufion of concurrent MEG and EEG (M/EEG) together with the high spafial resolution of fMRI. M/EEG will evaluate the synchrony of frequency band-specific neural acfivity in local and distributed circuits, including cross-frequency coordination, through integrated spectral and connectivity approaches. fMRI will evaluate, with precise and definitive anatomic localization, activity of local and distributed circuits using regional BOLD and funcfional connectivity approaches. Abnormalities in cortical layer 3 pyramidal cell function are predicted to have a direct impact on both local and distributed circuit processing. These abnormalities are refiected in impaired functional connectivity and cortical synchrony within and between DLPFC and PPC. Our findings will provide novel insights into the local and distributed circuit pathophysiology underlying executive control disturbances in schizophrenia, providing a systems-level link to cellular abnormalifies, thereby identifying physiological biomarkers for future novel therapeutic approaches.

Public Health Relevance

Cognifive dysfuncfion is the main contributor to social and occupafional problems in schizophrenia. This project will link knowledge about cellular pathology to cortical pathophysiology in medication naive subjects in a first-episode of psychosis, providing the foundation for the development of pathophysiologically-informed biomarkers for new therapeutic approaches.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
1P50MH103204-01
Application #
8816254
Study Section
Special Emphasis Panel (ZMH1-ERB-L (01))
Project Start
Project End
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
1
Fiscal Year
2014
Total Cost
$563,266
Indirect Cost
$186,390
Name
University of Pittsburgh
Department
Type
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Asafu-Adjei, Josephine K; Sampson, Allan R (2018) Covariate adjusted classification trees. Biostatistics 19:42-53
Chung, Daniel W; Chung, Youjin; Bazmi, H Holly et al. (2018) Altered ErbB4 splicing and cortical parvalbumin interneuron dysfunction in schizophrenia and mood disorders. Neuropsychopharmacology 43:2478-2486
Enwright Iii, J F; Huo, Z; Arion, D et al. (2018) Transcriptome alterations of prefrontal cortical parvalbumin neurons in schizophrenia. Mol Psychiatry 23:1606-1613
Huang, Ge; Ramachandran, Suchitra; Lee, Tai Sing et al. (2018) Neural Correlate of Visual Familiarity in Macaque Area V2. J Neurosci 38:8967-8975
Coffman, Brian A; Haigh, Sarah M; Murphy, Timothy K et al. (2018) Reduced auditory segmentation potentials in first-episode schizophrenia. Schizophr Res 195:421-427
Pafundo, Diego E; Miyamae, Takeaki; Lewis, David A et al. (2018) Presynaptic Effects of N-Methyl-D-Aspartate Receptors Enhance Parvalbumin Cell-Mediated Inhibition of Pyramidal Cells in Mouse Prefrontal Cortex. Biol Psychiatry 84:460-470
Hoftman, Gil D; Dienel, Samuel J; Bazmi, Holly H et al. (2018) Altered Gradients of Glutamate and Gamma-Aminobutyric Acid Transcripts in the Cortical Visuospatial Working Memory Network in Schizophrenia. Biol Psychiatry 83:670-679
Dorph-Petersen, Karl-Anton; Lewis, David A (2017) Postmortem structural studies of the thalamus in schizophrenia. Schizophr Res 180:28-35
Glausier, Jill R; Lewis, David A (2017) GABA and schizophrenia: Where we stand and where we need to go. Schizophr Res 181:2-3
Rocco, Brad R; DeDionisio, Adam M; Lewis, David A et al. (2017) Alterations in a Unique Class of Cortical Chandelier Cell Axon Cartridges in Schizophrenia. Biol Psychiatry 82:40-48

Showing the most recent 10 out of 36 publications